Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6340576rdf:typepubmed:Citationlld:pubmed
pubmed-article:6340576lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:6340576lifeskim:mentionsumls-concept:C0037047lld:lifeskim
pubmed-article:6340576lifeskim:mentionsumls-concept:C0005961lld:lifeskim
pubmed-article:6340576lifeskim:mentionsumls-concept:C0002874lld:lifeskim
pubmed-article:6340576lifeskim:mentionsumls-concept:C0867389lld:lifeskim
pubmed-article:6340576lifeskim:mentionsumls-concept:C0683956lld:lifeskim
pubmed-article:6340576lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:6340576pubmed:issue4lld:pubmed
pubmed-article:6340576pubmed:dateCreated1983-5-5lld:pubmed
pubmed-article:6340576pubmed:abstractTextOne hundred ten of 175 patients with aplastic anemia conditioned by cyclophosphamide had sustained engraftment of marrow from human leukocyte antigen (HLA)-identical siblings and lived for more than 6 months. Forty-nine of the 110 patients developed chronic graft-versus-host disease between 85 and 464 days. Ninety-seven patients are alive from 1.4 to 11 years after engraftment; 13 died between 208 and 726 days. Twenty of the 36 surviving patients with chronic graft-versus-host disease have Karnofsky performance scores of 100%, 7 of 90%, 5 of 80%, 1 of 70%, 2 of 60%, and 1 of 40%. Our analysis, using a binary logistic regression model, identified three factors predicting chronic graft-versus-host disease: moderate to severe acute graft-versus-host disease with an estimated relative risk of 11.65; increasing patient age; and the use of viable donor buffy coat cells in addition to the marrow to prevent graft rejection. The last two factors were significant only in patients without acute graft-versus-host disease.lld:pubmed
pubmed-article:6340576pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6340576pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6340576pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6340576pubmed:languageenglld:pubmed
pubmed-article:6340576pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6340576pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6340576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6340576pubmed:statusMEDLINElld:pubmed
pubmed-article:6340576pubmed:monthAprlld:pubmed
pubmed-article:6340576pubmed:issn0003-4819lld:pubmed
pubmed-article:6340576pubmed:authorpubmed-author:StorbRRlld:pubmed
pubmed-article:6340576pubmed:authorpubmed-author:ThomasE DEDlld:pubmed
pubmed-article:6340576pubmed:authorpubmed-author:BucknerC DCDlld:pubmed
pubmed-article:6340576pubmed:authorpubmed-author:CliftR ARAlld:pubmed
pubmed-article:6340576pubmed:authorpubmed-author:SandersJ EJElld:pubmed
pubmed-article:6340576pubmed:authorpubmed-author:PrenticeR LRLlld:pubmed
pubmed-article:6340576pubmed:authorpubmed-author:ShulmanH MHMlld:pubmed
pubmed-article:6340576pubmed:authorpubmed-author:WitherspoonR...lld:pubmed
pubmed-article:6340576pubmed:authorpubmed-author:StewartP SPSlld:pubmed
pubmed-article:6340576pubmed:authorpubmed-author:DoneyK CKClld:pubmed
pubmed-article:6340576pubmed:authorpubmed-author:DeegH JHJlld:pubmed
pubmed-article:6340576pubmed:authorpubmed-author:SullivanK MKMlld:pubmed
pubmed-article:6340576pubmed:authorpubmed-author:AppelbaumF...lld:pubmed
pubmed-article:6340576pubmed:issnTypePrintlld:pubmed
pubmed-article:6340576pubmed:volume98lld:pubmed
pubmed-article:6340576pubmed:ownerNLMlld:pubmed
pubmed-article:6340576pubmed:authorsCompleteYlld:pubmed
pubmed-article:6340576pubmed:pagination461-6lld:pubmed
pubmed-article:6340576pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6340576pubmed:meshHeadingpubmed-meshheading:6340576-...lld:pubmed
pubmed-article:6340576pubmed:meshHeadingpubmed-meshheading:6340576-...lld:pubmed
pubmed-article:6340576pubmed:meshHeadingpubmed-meshheading:6340576-...lld:pubmed
pubmed-article:6340576pubmed:meshHeadingpubmed-meshheading:6340576-...lld:pubmed
pubmed-article:6340576pubmed:meshHeadingpubmed-meshheading:6340576-...lld:pubmed
pubmed-article:6340576pubmed:meshHeadingpubmed-meshheading:6340576-...lld:pubmed
pubmed-article:6340576pubmed:meshHeadingpubmed-meshheading:6340576-...lld:pubmed
pubmed-article:6340576pubmed:meshHeadingpubmed-meshheading:6340576-...lld:pubmed
pubmed-article:6340576pubmed:meshHeadingpubmed-meshheading:6340576-...lld:pubmed
pubmed-article:6340576pubmed:meshHeadingpubmed-meshheading:6340576-...lld:pubmed
pubmed-article:6340576pubmed:meshHeadingpubmed-meshheading:6340576-...lld:pubmed
pubmed-article:6340576pubmed:meshHeadingpubmed-meshheading:6340576-...lld:pubmed
pubmed-article:6340576pubmed:meshHeadingpubmed-meshheading:6340576-...lld:pubmed
pubmed-article:6340576pubmed:meshHeadingpubmed-meshheading:6340576-...lld:pubmed
pubmed-article:6340576pubmed:meshHeadingpubmed-meshheading:6340576-...lld:pubmed
pubmed-article:6340576pubmed:meshHeadingpubmed-meshheading:6340576-...lld:pubmed
pubmed-article:6340576pubmed:year1983lld:pubmed
pubmed-article:6340576pubmed:articleTitlePredictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings.lld:pubmed
pubmed-article:6340576pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6340576pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:6340576pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6340576lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6340576lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6340576lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6340576lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6340576lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6340576lld:pubmed